Koers CannTrust Holdings Inc. Other OTC
Aandelen
CNTTQ
CA1378002077
Farmaceutische producten
Omzet 2017 | 20,7 19,36 | Omzet 2018 | 45,65 42,69 | Marktkapitalisatie | 508 mln. 475 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | 6 mln. 5,61 mln. | Nettowinst (verlies) 2018 | -13 mln. -12,16 mln. | EV/omzet 2017 | 31.215.427 x |
Nettoliquiditeiten 2017 | 17,16 mln. 16,05 mln. | Nettoliquiditeiten 2018 | 58 mln. 54,24 mln. | EV/omzet 2018 | 9.864.003 x |
K/w-verhouding 2017 |
81,5
x | K/w-verhouding 2018 |
-34,5
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-19 |
David Blair
DFI | Director of Finance/CFO | - | 01-10-19 |
Sales & Marketing | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-19 |
Dan Hogan
BRD | Director/Board Member | - | 17-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,04% | 5,92 mld. | |
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
-7,89% | 1,68 mld. | |
+0,09% | 1,65 mld. | |
-12,97% | 1,53 mld. |